The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

Adopt a prevention-first mindset and provide robust funding for adult vaccination programs Now, more than ever, healthcare systems must invest in strategies to cope with unprecedented and growing ...

The value of antibiotics often extends beyond what HTA captures. The STEDI framework aims to capture that broader value and our report outlines a roadmap to realising its full potential. Key Takeaways ...

This panel brings together leading researchers to explore how health economics can inform policy design in the context of the climate crisis. Rather than proposing new evaluative paradigms, the ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

We conducted a quantitative preference study to understand how well the criteria of NICE’s severity modifier align with UK societal preferences. Our primary objectives were to estimate: Cut-offs for ...

However, when these therapies involve two or more on-patent drugs from different manufacturers, assessing and pricing them can be challenging, potentially delaying or preventing patient access. One ...

New antibiotics are urgently needed, but their development is hindered by market failure. A ‘volume-delinked model’ subscription approach has been suggested to overcome this market failure, providing ...

In this report, we explore the status of access and uptake for NGS testing for lung cancer in Europe, develop the health economic case for NGS testing, and identify barriers and opportunities for ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...

Across the globe, drug shortages are becoming increasingly common. Key takeaways Drug shortages are a growing global concern, affecting multiple therapeutic areas. Shortages are often concentrated in ...